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An important level at which the expression of programmed cell death (PCD) genes is regulated is alternative splicing. Our
previous work identified an intronic splicing regulatory element in caspase-2 (casp-2) gene. This 100-nucleotide intronic
element, In100, consists of an upstream region containing a decoy 39 splice site and a downstream region containing binding
sites for splicing repressor PTB. Based on the signal of In100 element in casp-2, we have detected the In100-like sequences as
a family of sequence elements associated with alternative splicing in the human genome by using computational and
experimental approaches. A survey of human genome reveals the presence of more than four thousand In100-like elements in
2757 genes. These In100-like elements tend to locate more frequent in intronic regions than exonic regions. EST analyses
indicate that the presence of In100-like elements correlates with the skipping of their immediate upstream exons, with 526
genes showing exon skipping in such a manner. In addition, In100-like elements are found in several human caspase genes
near exons encoding the caspase active domain. RT-PCR experiments show that these caspase genes indeed undergo
alternative splicing in a pattern predicted to affect their functional activity. Together, these results suggest that the In100-like
elements represent a family of intronic signals for alternative splicing in the human genome.
Citation: Havlioglu N, Wang J, Fushimi K, Vibranovski MD, Kan Z, et al (2007) An Intronic Signal for Alternative Splicing in the Human Genome. PLoS
ONE 2(11): e1246. doi:10.1371/journal.pone.0001246
INTRODUCTION
As a major mechanism of genetic diversity by generating transcript
variability, alternative splicing affects every aspect of cell survival
and function. It is estimated that more than 60% of human genes
undergo alternative splicing [1]. A variety of splicing regulatory
elements have been identified by using molecular, biochemical,
and computational approaches. However, our understanding of
alternative splicing at the genomic level remains limited.
A large number of genes critical for cell death utilize alternative
splicing to generate functionally distinct or even antagonistic
isoforms [2,3]. These genes range from death signals, death
receptors, intracellular adaptor molecules to caspases [4,5]. To
understand mechanisms regulating alternative splicing events
important for cell death gene function, we previously established
a model system using the murine caspase-2 (casp-2) gene.
Exclusion or inclusion of exon 9 leads to the formation of two
functionally antagonistic isoforms, casp-2S or casp-2L respectively
[6,7]. Casp-2L and casp-2S have antagonistic activities in cell
death [6,8]. Dissection of cis-elements reveals an intronic element,
In100, which is important for regulating casp-2 alternative
splicing. In100 has two domains, an upstream one containing
a decoy 39 splice site and a downstream one with U/C-rich repeats
that interact with PTB [9,10].
In this study, we searched human genome for sequence
elements with features of In100 and identified 2757 genes
containing In100-like elements. These In100-containing genes
are subdivided in 1865 gene families. Gene ontology analysis
revealed that the products of these In100-containing genes are
involved in various biology processes. These elements are
significantly enriched in intronic regions. EST database analyses
revealed a correlation of such elements with the skipping of their
upstream exons. In addition, by RT-PCR, analyses of several
human caspase genes indicate that these In100-containing caspase
genes indeed undergo alternative splicing, with the skipping of
exons immediate upstream of their In100-like elements. Taken
together, these results support that In100-like elements represent
a family of sequence signals for alternative splicing.
RESULTS
A conserved intronic regulatory element, In100, in
the caspase-2 gene
In our previous studies, we established a casp-2 splicing model
system and identified In100 as an important cis-element for casp-2
alternative splicing [9,10]. This In100 element contains two
domains, both of which are required for its activity in suppressing
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contains a decoy 39 splice site, highly similar to an authentic 39
splice site, and a downstream domain with U/C-rich repeats
interacting with polypyrimidine tract binding protein, PTB [9,10].
Our biochemical experiments indicate that In100 engages in non-
productive interactions with the 59SS of exon 9, hence blocking its
usage by the spliceosome (Figure 1).
Comparative analyses of mouse and human casp-2 genomic
sequences reveal that In100 element is conserved, with 74%
nucleotide identity between mouse and human sequences
(Figure 2A), although the overall nucleotide sequence of intron 9
is not conserved. This suggests a common mammalian ancestral
In100-like element and the functional importance of In100-like
elements in mammalian species. These observations raise
a conjecture that the In100-like elements may represent a sequence
motif regulating alternative splicing of many different genes.
Testing this conjecture may help address several questions. First,
are these In100-like elements wide spread in the human genome?
Second, how are they distributed in the genome, e.g. among
intronic and exonic regions? Third, is the presence of such
elements associated with alternative splicing events in the human
genome? To answer these questions, we designed the following
bioinformatics and experimental approaches to search for and
analyze In100-like elements in the human genome.
In100-like sequence elements are widespread in the
human genome
To test the hypothesis that a 39 splice site-like sequence juxtaposed
to U/C rich sequence may represent a general motif associated
with alternative splicing, we screened the human genome for genes
containing such sequences. First, an exon-intron sequence
database was created containing all annotated human genes. An
algorithm was developed to search for In100-like elements in this
database. This algorithm used a 100-nucleotide sliding window to
scan for the In100 signals from the 59 to the 39 end along each
DNA sequence in the database. In100 signal is defined as:
UAAC[branch site]-5,10nt-(Py)n[polypyrimidine tract]-N3-(U/C
rich, 20–60 nt), where n is bounded around 30,40, ‘‘U/C rich’’ is
defined as U/C content higher than 70%, and N3=CAG. We also
tested N3=TAG, AAG and GAG (see below) and investigated the
relative importance of these trinucleotides in defining 39SS [11].
This search revealed 4342 candidate sequences with the features of
In100 in 2757 genes (Table S1), suggesting that In100-like
elements may represent a general sequence motif. The nucleotide
composition of these In100-like elements was analyzed using
PERL scripts and Web-Logo [12], as displayed in Figure 2B.
Gene family analysis showed that these In100-containing genes
can be classified into 1865 gene families (Table S2). Gene ontology
analysis showed that these genes are involved in various biological
processes, molecular function and encoding different cell compo-
nents (Figure 3). Among overrepresented In100-containing genes
are those involved in biological processes of biopolymer modifi-
cation, protein modification process, post-translation protein
modification, with molecular functions of protein kinase activity,
ATP binding and phosphotransferase activity and encoding cell
components of basement membrane, cell membrane and synapses
(Table S3).
The significant enrichment of In100-like elements in
intronic regions
To address whether these In100-like sequences are randomly
distributed in intronic and exonic regions, we designed two tests.
First, we compared the observed and expected frequencies of the
candidate In100 elements in intronic and exonic sequences based
on their total length distribution. The lengths of introns and exons
for In100-containing genes were calculated, and frequencies of
candidate In100 sequences were compared. If these In100-like
elements were equally distributed, we would expect their
frequencies in the intronic versus exonic regions to be 94.2%
and 5.8% respectively, proportional to the relative lengths of
introns and exons in the human exon-intron sequence database
constructed (see Methods). As shown in Table 1, there is a positive
bias towards intronic distribution (98.5%), and a negative bias
towards exonic distribution (1.5%) (x
2=189.2, degree of freedom
(df)=1, P<0). Thus, these In100-like elements are not randomly
distributed and instead, significantly enriched in intronic regions.
Additionally, we examined the distribution pattern of In100-
elements in randomized human intron-exon databases. By
simulation, we randomized the nucleotide sequences of human
intron-exon database but maintaining the same exon-intron
structure and nucleotide compositions (see Methods). We found
that the frequency of In100-elements decreases by almost an order
of magnitude in the randomized databases (Figure S3), as
compared to the In100-element frequency observed in the real
human intron-exon database. Thus, the significant decrease of
In100-elements in the randomized human database indicates that
there is a significant enrichment of In100-element in the human
genome and that the detected genomic distribution of In100 in the
human genome is not a statistical coincidence.
Next, we analyzed the trinucleotide sequences inside the decoy
39 splice site of the In100 elements (i.e., in ‘‘N3’’ position).
Genomic analyses have shown that in intronic regions, CAG are
present more frequently than expected at the last three nucleotide
positions as 39 splicing signal [11,13]. Thus, if the detected In100-
like sequences are intronic elements; in intronic regions, the
frequency of the defined elements with CAG-(U/C rich, 20-60nt)
should be higher than its expected frequency, whereas the
elements with TAG, GAG, or AAG should be observed in
depletion, or at least not in excess. In addition, the excess of In100-
elements with CAG should be exclusively observed in the intronic
regions, not in exonic regions. We analyzed and compared the
number of In100-like elements with CAG, AAG, GAG, and TAG
as N3 in intronic and exonic regions respectively. Respectively, we
identified 4277, 4643, 3814 and 5126 In100-like sequences in the
intronic regions, and 65, 95, 57 and 80 in the exonic regions. As
shown in Table 2, the frequency of CAG containing In100
elements are significantly higher in the intronic regions and lower
Figure 1. A diagram depicting In100 and its role in regulating casp-2.
As demonstrated by our previous studies [9,10], sequential deletion and
biochemical experiments reveal that In100 in casp-2 gene represses
exon 9 inclusion by engaging non-productive interaction with the 59
splice site of exon 9. Interactions between U1 snRNP associated with
exon 9 at the 59 splice site and complexes associated with In100,
including U2 snRNP and PTB, block rather than promote the selection of
this 59 splice site. The In100 element is diagramed as the hatched box.
Exons 8, 9 and 10 are depicted as E8, E9 and E10 in gray boxes. U1
snRNP and U2 snRNPs are illustrated as U1 and U2.
doi:10.1371/journal.pone.0001246.g001
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In100 elements are enriched in intronic regions.
The presence of In100 element correlates with
skipping of its upstream exons
If In100 elements play a role in suppressing the inclusion of the
immediate upstream exons, similar to that in caspase-2 gene
(Figure 1; see the previous studies [9,10]), it would be predicted
that In100 immediate downstream exons would be more likely to
appear in the human transcriptome than the immediate upstream
exons. This prediction was tested by examining the relative
abundance of the transcripts containing the upstream or
downstream exons of In100-element in the human EST database.
We isolated in silico the immediate upstream and downstream
exons for 4277 In100-elements in the intronic regions and
searched human EST databases for the transcripts that contain
exons flanking In100-elements. We used equal or higher than 98%
identity and 70% exon length coverage as alignment criteria to
determine the match of an EST with a particular exon sequence. If
an exon-EST alignment satisfied these criteria, we assumed the
EST was transcribed from the exon. Among the 4277 sequences,
we found 2728 In100-elements (in 2012 genes) that have both
upstream and downstream exons annotated with ESTs. The
frequency of ESTs representing the downstream exons of the
In100-element is 12.5% higher than that of the upstream exons
(Figure 4).
In order to examine whether this increase in the frequency of
ESTs representing the exons immediately downstream of In100-
elements is associated with the presence of In100-elements, we
constructed and analyzed the negative control exon pairs of In100-
elements. We selected exon pairs that do not immediately flank
those elements from the same 2757 In100-element containing
genes. In this set of 23624 pairs of control exons, the frequency of
ESTs representing the downstream exons is only 1.7% higher than
that of the upstream exons. The difference in the comparison of
In100-element flanking exons and the control exon pairs is highly
significant (Fisher’s Exact Test, P,2.2610
216, df=1; Figure 4).
This control group of exon pairs also works as a control for
over-representation of the downstream exons as a result of the
biased cDNA cloning or EST distribution. Namely, the observed
gradient of EST representation could merely be a reflection of an
uneven EST distribution in the EST database, rather than the
skipping of the In100- upstream exons. If this were true, we should
expect to find a higher frequency of ESTs matched to the
downstream than the upstream exon in the control group as well,
since our control exon pairs show the same distribution of position
along the mRNA sequences as the In100-element flanking exons
(Figure S1). The highly significant difference (Fisher’s Exact Test,
P,2.2610
216) between the differential EST frequency (down-
stream versus upstream exons) of the In100-containing exon pairs
(12.5%) and the control group (1.7%) indicates that the observed
gradient is not a result of biased EST distribution along the
mRNA transcripts. This excess of downstream exons of In100-
containing sequences in the human transcriptome supports the
association between upstream exon skipping and the presence of
In100-like elements.
In order to verify and quantify this association, we examined
three-exon cassette sequences and compared middle exon skipping
(Figure 5A) in In100-element containing genes versus In100-
Figure 2. The evolutionary conservation of casp-2 In100 element and nucleotide composition of In100-like elements. (A) Alignment between
human and mouse casp-2 In100 elements shows 74% sequence identity. Putative branch site A is in bold and underlined (BS). The polypyrimidine
tract in the decoy 39splice site (Py)n and CAG are indicated. (B) The nucleotide composition is displayed based on the identified 4342 In100 elements.
doi:10.1371/journal.pone.0001246.g002
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containing exon triplets (e.g. exon1-exon2-In100-exon3;
Figure 5A), the presence of ESTs representing both complete
exon1-exon2-exon3 transcript and exon2-lacking transcript (i.e.,
exon1-exon3) indicates the alternative splicing event with exon2
skipping. However, due to the possible incompleteness of ESTs
database, such exon-skipping evidence may not be found for every
exon triplet. Therefore, from In100-containing genes, we only
included the ones with sufficient EST information, namely the
ones showing at least one EST simultaneously matching exon1
and exon3 (with/without exon2). Among them, 1470 triplets (from
1252 genes) are In100-containing exon triplets, and 15943 triplets
(from 2036 genes) are In100-lacking exon triplets. These two
groups of exon triplets have similar distribution of position along
mRNA sequence (Figure S2). We treated the former group as the
experimental set and the latter group as the control set. In the
experimental set of 1470 In100-containing exon triplets, 524
triplets (36% of 1470) have at least one EST presenting exon 2
skipping; whereas in the control set of 15943 In100-lacking exon
triplets, only 4116 triplets (26%) have such ESTs (Figure 5B and
Table S6). Fisher’s Exact Test showed that the frequency of the
exon-skipping events is significantly higher in In100-containing
exon triplets than In100-lacking ones (P,2.3610
215). These 524
In100-containing exon triplets are from 482 genes (Table S4).
Thus, 38% (482 out of 1252) of these In100-element containing
genes show EST evidence for the skipping of exons immediate
upstream of In100-residing introns.
Finally, we searched AltSplice [14] Database, a data source
recording alternative-splicing events. We identified 69 In100-
containing genes with clear evidence of skipping of exons upstream
of the In100 element (Table S5). Twenty-five of these 69 genes
were the same as the ones identified by our ESTs analysis. Thus,
we have identified 526 In100-containing genes that have evidence
of skipping of exons immediately upstream of In100-elements.
These results provide strong evidence for the correlation of In100-
elements with the skipping of their immediate upstream exons.
Figure 3. The distribution of gene ontology of In100-containing genes. The distribution of gene ontology terms of the In100-containing genes in
(A) Biology Process, (B) Molecular Function and (C) Cell Component.
doi:10.1371/journal.pone.0001246.g003
Table 1. Intronic versus exonic distribution of In100-like
elements identified in human genome
......................................................................
Exons Introns Sum
Observed No. 65(1.5%) 4277 (98.5%) 4342 (100%)
Expected No. 251(5.8%) 4091 (94.2%) 4342(100%)
(O-E)
2/E 137.8 8.5 146.3
Total lengths 65,661,947 1,068,751,168 1,134,413,115
x
2=146.3 for df=1, P>0, revealing a highly significant excess of In100 element
candidates in intronic regions.
doi:10.1371/journal.pone.0001246.t001
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PLoS ONE | www.plosone.org 4 November 2007 | Issue 11 | e1246The presence of In100-like elements in caspase
genes and their alternative splicing
The analyses of human genomes described above have revealed
a large number of In100-like elements and provide an opportunity
to further investigate predicted alternative splicing patterns of the
output candidate genes. Because In100 was first identified in casp-
2 gene, we asked whether such elements are also found in other
caspase genes. Indeed, the In100-like element was found in several
human caspase gene sequences, including caspase 2, 3, 8 and 9
(Table 3). We systematically analyzed human caspase gene
structures and examined the location of these In100-like elements.
Interestingly, the In100-like elements in these caspase genes are
located in introns adjacent to exons encoding caspase active sites
with ‘‘QACXG’’ signature motif (Figure 6A). If these In100-like
elements act to suppress the inclusion of the upstream exon, as
predicted by our casp-2 study, such alternative splicing events will
have significant functional impact because of the formation of
isoforms that either contain or lack the caspase catalytically active
domain.
We used two approaches to confirm these predicted alternative-
splicing events in the corresponding caspase genes. First, we
searched human EST and cDNA databases and aligned
corresponding ESTs with the genomic sequences of these caspase
genes. In each of the caspase genes examined, there are EST or
cDNA sequences indicative of alternative splicing. The presence of
these EST or cDNA sequences indicates that these caspase genes
are alternatively spliced in this region. More importantly, caspase-
2, 3, 8 and 9, all undergo alternative splicing in the exon encoding
QACXG motif, the caspase active site.
We then used a RT-PCR assay to examine the alternative
splicing of selected caspase genes in human cells. Using specific
Table 2. Frequency of defined trinucleotides of decoy 39 splice sites in candidate In100 elements (numbers observed and expected
for introns/exons)
..................................................................................................................................................
CAG AAG GAG TAG Total
Intronic Exonic Intronic Exonic Intronic Exonic Intronic Exonic Intronic Exonic
Obs No. 4277 65 4643 95 3814 57 5126 80 17860 297
Exp No. 3572 73 5001 77 3750 74 5537 73 17860 297
Excess (O-E/E)6100 19.7 211 27.2 23 1.7 223 27.4 10
(O-E)
2/E 139.1 0.877 25.6 4.21 1.1 3.9 30.5 0.67 196.3 9.7
x
2=196.3 for df=3 indicates a probability that is very low (P=4.2610
242), thus there is a significant excess (,20%) of the In100 element candidate as defined by CAG at
the last three positions of the decoy 39 splice site inside the In100-like elements located in introns. The opposite pattern is observed for CAG inside the In100-like
elements located in exons: depletion of 11% (X
2=9.7 for df=3; P=0.021). The expected numbers were calculated separately by the nucleotide composition of intronic
regions: 0.28 for A, 0.31 for T, 0.20 for C and 0.21 for G; and of exonic regions: 0.258 for A, 0.246 for T, 0.246 for C and 0.25 for G [43].
doi:10.1371/journal.pone.0001246.t002
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Figure 4. A biased distribution of transcripts favoring the downstream exons as revealed by EST analyses. ESTs frequency of upstream (59) and
downstream (39) exons. The sample sizes for analyzed In100-element flanking exons and control exon pairs are: 2728 and 23624, respectively.
doi:10.1371/journal.pone.0001246.g004
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RT-PCR assay, we confirmed that casp- 2, 3, 8 and 9 all undergo
alternative splicing as predicted (Figure 6B). These experimental
data suggest that the presence of In100-like elements has
a predictive value for alternative splicing and strongly support
the hypothesis that In100 elements represent intronic signals for
alternative splicing.
DISCUSSION
In this study, we employed bioinformatics and experimental
approaches to search for sequence signals associated with
alternative splicing. Our data reveal that In100, originally
identified in the mouse casp-2 gene, is present in thousands of
unrelated human genes and possibly involved in regulating their
alternative splicing. Of 1252 In100-containing genes for which
sufficient EST information is available, 482 genes display skipping
of exons immediate upstream of the In100-residing introns. An
additional 44 In100-containing genes with such alternative splicing
pattern are found in AltSplice Database [14]. The experimental
analyses of elements found in human caspase genes, including
casp-2, 3, 8 and 9, confirmed that these genes indeed undergo
alternative splicing in the regions containing In100-elements. Our
analyses support that In100 elements represent a family of intronic
sequence motif involved in alternative splicing of many different
genes.
Alternative splicing is a complex process involving interactions
between multiple trans-acting factors with a large number of cis-
acting regulatory elements. Identifying the In100-like elements in
a large number of genes does not necessarily predict identical
splicing patterns of these genes in different cell types, because
In100-elements may interact with different cis- regulatory
elements in different genes and trans-acting factors in different
types of cells. How these unknown factors interact with In100-
elements and define the alternative splicing patterns are interesting
problems to be addressed by further experiments. The large
number of In100 containing genes, each with its specifics in
interaction with In100 elements, provides tremendous opportuni-
ties for the research community to further investigate detailed
mechanisms of alternative splicing regulation in these genes (Table
S1).
Intronic and exonic regulatory elements can enhance or
suppress splicing, including exonic splicing enhancers (ESEs),
intronic splicing enhancers (ISEs) or exonic splicing silencers
(ESSs) and intronic splicing silencers (ISSs). Most of these cis-
acting regulatory elements have been identified by biochemical
and molecular studies of alternative splicing of individual genes of
interest, (for recent reviews, see [15–20]). Programs predicting
exonic splicing elements based on systematic evolution of ligands
by exponential enrichment (SELEX) approach and computational
analyses have been developed (for example, http://exon.cshl.org/
ESE, also see [21–26]). Recently, a ternary combination of exonic
UAGG and 59-splice-site-proximal GGGG motifs have been
reported that function cooperatively to silence the brain-region-
specific CI exon 19 of the glutamate NMDA R1 receptor
transcript [27].
A variety of intronic splicing regulatory elements have been
identified using biochemical approaches. Only a few studies have
reported systematic approaches to search for intronic regulatory
elements. Analyses of small vertebrate introns suggest that GGG-
containing sequences may act as intronic splicing enhancers in
small introns [28]. A study of brain-enriched alternative exons
shows that putative intronic splicing enhancers containing
UGCAUG motif are often found in introns flanking alternatively
spliced exons [29]. Analyses of 54 alternatively spliced exons
revealed C-rich and G-rich sequences in the flanking introns [30].
In100 element has a complex structure. Most of the previously
reported splicing regulatory elements, especially those identified by
computational approaches, are in the range of 6-15mers [22–30],
whereas In100-like elements described here are about 100
nucleotides in length, containing the decoy 39 splice site domain
and the pyrimidine-rich domain.
A role for pseudo-splice sites in regulating splicing has been
suggested by previous studies. In Drosophila P-element intron 3
splicing, a pseudo 59 splice site competes with the normal 59 SS for
interaction with U1 snRNP [31]. A sequence similar to a 59 splice
site [32] and a U-rich element adjacent to the regulated 59 splice
site [33] have been reported to act as intronic splicing repressors.
In C. elegans, an alternative exon in U2AF65 pre-mRNA contains
multiple copies of 39 splice site consensus sequences [34]. These
single case studies appeal for further studies at the genomic level.
Our study of In100-elements suggests that decoy 39 splice sites
juxtaposed to pyrimidine-rich sequences may act as general signals
for alternative splicing.
Mechanisms by which the decoy 39 splice site of In100 is
recognized as a signal for alternative splicing rather than an
Figure 5. The alternative splicing of In100-containing genes. (A) A
diagram depicting the alternative splicing of In100-containing
genes. In100-containing genes were identified with three flanking
exons (E1 to E3) from EST database, illustrated as E1-E2-In100-E3. 482
genes from EST database and an additional 44 genes from AltSplice [14]
Database, with a total of 526 different genes show exon 2 skipping. (B)
A higher frequency of skipping of exon2 in In100-containing exon
triplets revealed by EST analyses. Frequency of skipping of exon2 in
In100-containing and In100-lacking exon triplets by EST evidence is:
36% and 26%, respectively. The sample sizes for analyzed In100-
containing and control exon triplets are: 1470 and 15943, respectively.
doi:10.1371/journal.pone.0001246.g005
Table 3. The Ensembl gene ID and transcript ID used to assign
exon numbers
......................................................................
Gene Ensembl gene ID Transcript ID
Casp-2 ENSG00000106144 ENST00000350623
Casp-3 ENSG00000164305 ENST00000308394
Casp-8 ENSG00000064012 ENST00000303385
Casp-9 ENSG00000132906 ENST00000333868
doi:10.1371/journal.pone.0001246.t003
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PLoS ONE | www.plosone.org 6 November 2007 | Issue 11 | e1246authentic 39 splice site remain to be elucidated. PTB binding to the
downstream domain of In100 plays an important role [10]. Our
biochemical studies suggest the involvement of additional factors
[9], (KF and JYW unpublished results). We noticed that some of
In100-like elements contain polyU or polyC stretches that do not
resemble typical PTB-binding sites. It is conceivable that such
sequences may interact with other splicing regulatory factors.
In100 elements are distinct from other intronic splicing
regulatory elements, including splicing suppressor elements
containing hnRNP A1 or PTB binding sites, reviewed in
[16,17,35,36], UGCATG-containing elements [29], U/G-rich
intronic elements that interact with CUG-repeat binding proteins,
reviewed in [16] or (UCAUY)3-containing sequences binding to
Nova proteins [37] or the C-rich and G-rich motifs [27,30]. We
examined these known splicing suppressor sequences and did not
find sequence features of In100-elements.
Although a great number of human EST sequences have been
generated, we were only able to obtain 2259 In100-element
containing genes with flanking exons annotated with EST
sequences. These ESTs clearly show a gradient distribution, with
significantly higher frequency of EST representation of the exons
immediate downstream of In100-containing introns. Analyses of
In100-containing sequences annotated with further upstream and
downstream exons in 1252 genes revealed 526 genes that have
EST evidence of alternative splicing, showing that the presence of
In100 elements correlates with the skipping of their immediate
upstream exons. As we focused on In100-containing genes with
sufficient EST data, these 526 genes only represent a small subset
of possible alternative spliced genes. The observation that In100
elements exist in different gene families and their correlation with
alternative splicing provides an opportunity for further study of
In100 elements as a genomic signal for alternative splicing.
The finding that the exons upstream of In100 are often skipped
corroborates with the alternative splicing patterns observed for
several caspase genes, including casp-2, 3, 8 and 9. Some of these
splicing isoforms have been reported as distinct cDNAs with
different biological activities [8,9,38–40]. Our experiments also
reveal previously unknown splicing isoforms, Casp-8x and Casp-
9x, as a result of skipping of exons upstream of their In100-
containing introns (Figure 6). These splicing isoforms encode
products lacking the caspase active domain. It is obvious that the
dosage of active caspases has to be tightly controlled in response to
different cell death signals. By generating enzymatically active
versus inactive isoforms, alternative splicing provides an excellent
mechanism for fine-tuning the level of active caspases at the post-
transcriptional level.
MATERIALS AND METHODS
Construction of a human exon-intron sequence
database
The sequence and intron/exon annotation of each gene in human
genome were downloaded from BioMart, annotated by EN-
SEMBL 44 GENES (SANGER), (http://www.biomart.org). We
Figure 6. Alternative splicing of caspase genes. (A) A schematic illustration of In100-like elements in caspase genes and their alternative
splicing patterns. Exons are depicted in rectangles, and In100 elements are illustrated as small gray boxes. The positions of regions encoding
‘‘QACRG’’ pentapeptide sequence are marked with ‘‘*’’. (B) Alternative splicing of Caspase 2, 3, 8, 9 genes as detected by RT-PCR. Specific primers
corresponding to the upstream and downstream exons were used in RT-PCR as described in Materials and Methods. The sizes of each exons are not
drawn to scale. The positions of PCR primers are marked by arrows.
doi:10.1371/journal.pone.0001246.g006
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most exon to the 39 most exon of all transcripts, including all
coding and non-coding exonic sequence as well as intronic
sequences. In addition, exon and intron positions as well as
description of gene sequences were recorded.
Creation of an algorithm to scan In100 candidate
sequences
A program was written in C language to search In100 candidate
sequences in the human exon-intron sequence database. In the
program, we designed a sliding window along the DNA sequences
to move from the 59 to the 39 end of each sequence. The sliding
window is 100 nt in length based on the length of the In100
element defined by biochemical experiments on casp-2. The signal
of In100 was defined as: UAAC[branch site]-5-10 nt-(Py)n[poly-
pyrimidine tract=U/C rich]-CAG-(U/C rich, 20–60 nt). The
program searched candidate sequences for In100 elements and
recorded their locations in introns or exons, the locus names as
well as the description of the gene. The nucleotide composition of
In100-like elements in the regions with the features contributing to
the alternative splicing was analyzed, using Web-Logo [12]
(http://www.weblogo.berkeley.edu) and PERL scripts.
Analysis of Gene ontology and Gene super-family
Both Gene family and Gene Ontology information were down-
loaded from BioMart, anotated by ENSEMBL 44 GENES
(SANGER), (http://www.biomart.org). The classification of
In100-containing genes into gene families was executed with
PERL scripts. The GO terms were binned into MGI GO_Slim
categories, using MGI GO_Slim Chart Tool (http://proto.
informatics.jax.org/prototypes/GOTools/web-docs/MGI_GO_
Slim_Chart.html). With GOstat [41] (http://gostat.wehi.edu.au/),
the GO distribution of In100-containing genes and all Ensemble
annotated human genes were compared and the over-presented
GO terms in In100-containing genes were revealed.
Analysis of the factors associated with the
enrichment of In100-elements
To construct the control set for analyzing the factors associated with
the enrichment of In100-elements, we generated 1000 intron-exon
databases by simulation. In each simulated intron-exon database,
we randomly generated a) 1500 genes; b) for each gene, the number
of exons and introns are 7 and 6, since the average number of exon
and intron in the real human intron-exon database per gene is 7.3
and 6.3; c) for each exon and intron sequence, the frequencies of
their nucleotide composition are the same as the ones in the real
human intron-exon database; d) the distribution of the length of
intronic and exonic regions are the same as those in the real
database.ThenwesearchedIn100-elementsequencesinthose1000
simulated intron-exon databases. We found that the total number of
In100-elements found in the simulated databases is 8 times lower
than the observed one in the real human intron-exon database. We
also normalized these numbers by the total length of the
corresponding databases (i.e. the frequency of In100-elements)
and compared the frequency of In100-elements in the simulated
database with the one observed in the human genome. The
frequency of In100-elements in the human genome is significantly
different from that detected in the simulated databases (Figure S3).
Sequence analyses and statistical tests
To determine whether the detected In100 candidates are
authentic intronic elements or random sequences, we used two
approaches: (1) Comparing the frequencies of the candidates in
exons and introns based on the total length distribution of exons
and introns; (2) examining the frequency of trinucleotide (CAG,
TAG, GAG and AAG) at the last three positions of the decoy 39
splice sites in intronic and exonic regions, respectively.
First, a chi-square test was used to compare the observed
frequency distribution of the elements in introns and exons with
the expected frequency distribution based on the ratio of total
exon length over total intron length with a degree of freedom of 1.
Second, if the frequency differences of the In100 candidate in the
four types (CAG, TAG, GAG, and AAG) are a consequence of
random distribution of nucleotide composition, they are expected
to be proportional to the frequency of four nucleotides A, T, G, C,
in the human intronic and exonic regions respectively. We thus
used human nucleotide frequencies in the intron and exon
sequences as a theoretical expectation of the four types of
candidate elements. Chi-square test was used to test the difference
between observed and expected distribution with a degree of
freedom of 3.
The Human EST database was downloaded from ncbi.nlm.-
nih.gov (dbEST release 041405). The pairs of immediate flanking
exons of 4277 In100-elements (located within introns) were
extracted according to the Ensembl 44 gene annotation. For
In100-element lacking control group, we selected exon pairs
located in the same In100-element containing genes by excluding
exon pairs that immediately flank an In100-element. The first or
the last exons of the genes were also excluded to avoid
compounding effects due to potential influence of alternative
promoter usage or alternative polyadenylation. In order to
quantitatively analyze the splicing pattern of an exon pair, we
separately aligned each exon against the human EST database
using BLAT [42]. Alignments with sequence identity equal or
higher than 98% that cover at least 70% exon length were used as
the criteria to identify the match of an EST with a particular exon.
From 2757 In100-containing genes, we chose the triple exon
cassettes with sufficient EST information, namely the ones with at
least one EST simultaneously representing Exon1 and Exon3
(with/without Exon2). Alignments with at least 98% sequence
identity and 70% exon length coverage were used as the criteria to
identify the representation of an EST with particular exons. Next,
In100-containing exon triplets (i.e. exon1-exon2-In100-exon3) and
In100-lacking exon triplets (i.e., exon triplets not overlapped with
In100-containing ones) were separated as experimental and
negative control sets. The presence of ESTs with exon1-exon3
(lacking exon2) sequences is considered as the evidence of skipping
of Exon2. Thus, the frequencies of exon2 skipping were computed
for In100-containing or In100-lacking exon triplets respectively
(Table S6). In addition, AltSplice [14] database (www.ebi.ac.uk/
asd/altsplice) was searched for In100-element containing genes.
All the intermediate steps were carried out with PERL scripts.
RT-PCR detection of alternative splicing of caspases
RNA was extracted from HEK293 cells for detecting human
caspase gene alternative splicing. Specific primers corresponding
to the exonic regions of human caspase genes were used to detect
splicing isoforms by RT-PCR with the previously described
protocol [9]. The corresponding splicing isoforms were verified by
sequencing.
SUPPORTING INFORMATION
Table S1 List of 4342 sequences containing In100-like elements.
Found at: doi:10.1371/journal.pone.0001246.s001 (1.85 MB
PDF)
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PLoS ONE | www.plosone.org 8 November 2007 | Issue 11 | e1246Table S2 List of 1865 gene families involved in the 2491 In100-
containing genes. These gene families are ordered by the number
of In100-containing members in each family.
Found at: doi:10.1371/journal.pone.0001246.s002 (0.35 MB
XLS)
Table S3 The top over-presented GO terms of In100-containing
genes revealed in Biology Process, Molecular Function and Cell
Component.
Found at: doi:10.1371/journal.pone.0001246.s003 (0.04 MB
XLS)
Table S4 List of skipped In100-element upstream exon.Among
total 524 cases, 395 show EST retaining and skipping the
immediate upstream exons, and 129 present only EST skipping
them.
Found at: doi:10.1371/journal.pone.0001246.s004 (0.27 MB
XLS)
Table S5 List of 75 In100-like sequences (in 69 genes) with
evidence of skipping of In100 upstream exon, identified from
AltSplice [14] database
Found at: doi:10.1371/journal.pone.0001246.s005 (0.02 MB
XLS)
Table S6 The frequencies of exon2 skipping of experimental
and control exon triplets by EST evidence.
Found at: doi:10.1371/journal.pone.0001246.s006 (0.07 MB
PDF)
Figure S1 Upstream exon positional distribution along the
mRNA sequence.(A) In100-element flanking exon pairs (2728). (B)
Negative Control exon pairs (23624).
Found at: doi:10.1371/journal.pone.0001246.s007 (0.02 MB PDF)
Figure S2 The 59 end positional distribution along the mRNA
sequence. (A) In100-containing exon triplets (524). (B) In100-
lacking exon triplets (4116)
Found at: doi:10.1371/journal.pone.0001246.s008 (0.03 MB
PDF)
Figure S3 The frequency of In100-elements found in the
randomized exon-intron databases and in the human genome
In100 frequency: the number of In100 elements per million nt in
the sequence database. The histogram of the frequency of In100-
elements found in simulated databases is in black and the range of
those frequencies is: 0 - 0.89 per million nt, the mean is 0.54 per
million nt and the standard deviation is 0.10 per million nt; the
frequency of In100-elements in the real human intron-exon
database is in red and the value is 3.8 per million nt. The
probability to observe such frequency of In100-elements in
a randomized database is less than 0.001.
Found at: doi:10.1371/journal.pone.0001246.s009 (0.02 MB
PDF)
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